HIGHLIGHTS
- who: Jishu Gu et al. from the Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu, China have published the research work: EfficacyofApatinibplusS-1TherapyintheTreatmentofAdvanced Gastric Cancer Patients and the Effect on the Levels of Tumor Markers and Th1 and Th2-Like Cytokines, in the Journal: Evidence-Based Complementary and Alternative Medicine of 27/04/2022
- what: This study showed that the S-1 therapy plus apatinib was associated with a significantly higher efficacy versus S-1 therapy alone, indicating a better treatment efficiency after the application of apatinib.
SUMMARY
Gastric cancer is . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.